Money NewsMoney News

Dr Michael Thurn, CEO of PharmAust

View descriptionShare

Good data coming out of research for motor neurone disease has helped the share price of PharmAust lift by 84% over the last month.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 2 playlist(s)

Money News

Money News β€” the most respected business program on radio. If you crave the latest insights into su… 
Social links
Follow podcast
Recent clips
Browse 12,901 clip(s)